U.S. Markets open in 10 hrs, 10 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.95 | 132.79 | 1.29% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.24 | 14.86 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 6.19 03:36 PM EST | |
|---|---|---|
| Day High | 6.49 09:33 AM EST |
|
| Range | 0.30 |
| Volume | 262,859 | |
|---|---|---|
| 30-Day Avg Vol | 388,000 |
|
| Difference | -32.25% |
| Market Cap | 572.79 M | |
|---|---|---|
| Mkt Cap Chg | -10.99 M |
| Shares Out | 91.64 M | |
|---|---|---|
| % Shrs Traded | 0.29% | |
| 1yr EPS Est | -0.604 |
| 52-Wk Low | 2.60 | |
|---|---|---|
| 52-Wk High | 8.09 |
|
| Range | 5.49 |
| Prev Close | 6.37 11/20/09 | |
|---|---|---|
| Today's Open | 6.45 | |
| Change | 1.26% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.13 M |
| Revenue (LFY) | 8.76 M | |
|---|---|---|
| Earnings (LFY) | -48.65 M | |
| Earnings (MRQ) | -13.91 M | |
| Next Earn Est | -0.16 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.75 | |
| 1yr EPS Growth | 20.53% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -10.00 | |
| PEG Ratio | — | |
| Return on Equity | -131.17 | |
| Beta | 1.57 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on recombinant human PH20, a human synthetic enzyme it hopes will offer safety benefits ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.16 3/8/10 | — — |
—
—
|
| Last Quarter | -0.178 9/30/09 | -0.16 9/30/09 |
0.018
Beat
|
| 2 Quarters Ago | -0.167 6/30/09 | -0.21 6/30/09 |
-0.043
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.03 M | 8.76 M |
| Gross Profit | 2.56 M | -35.80 M |
| Operating Income | -13.94 M | -49.80 M |
| Net Income | -13.91 M | -48.65 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts